About RenovoDerm
RenovoDerm is a company based in Columbus (United States) founded in 2016. RenovoDerm has raised $775 thousand across 4 funding rounds. RenovoDerm offers products and services including Phoenix Wound Matrix and Anthem Wound Matrix. RenovoDerm operates in a competitive market with competitors including Imbed Biosciences, Organogenesis, Cour Pharma, Sofregen and BioTissue, among others.
- Headquarter Columbus, United States
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Renovoderm, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$775 K (USD)
in 4 rounds
-
Latest Funding Round
$250 K (USD), Debt – Conventional
May 09, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RenovoDerm
RenovoDerm offers a comprehensive portfolio of products and services, including Phoenix Wound Matrix and Anthem Wound Matrix.
Synthetic polymer for enhancing wound healing and tissue regeneration.
Advanced matrix to support healing of chronic wounds and burns.
People of RenovoDerm
Unlock access to complete
Unlock access to complete
Funding Insights of RenovoDerm
RenovoDerm has successfully raised a total of $775K across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $250 thousand completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by RenovoDerm
Investment portfolio details for RenovoDerm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RenovoDerm
Detailed financials for RenovoDerm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Renovoderm Comparisons
Peer comparison for RenovoDerm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RenovoDerm
RenovoDerm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Organogenesis, Cour Pharma, Sofregen and BioTissue, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Regenerative therapies for wound care are developed and commercialized.
|
|
| Locked | Locked | Locked |
Biotech nanoparticles are developed for immune disease treatments.
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of patch system for wound healing
|
Detailed competitors of RenovoDerm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renovoderm
Complete news archive for RenovoDerm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RenovoDerm
RenovoDerm was founded in 2016 and raised its 1st funding round 1 year after it was founded.
RenovoDerm is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.
RenovoDerm is a funded company, having raised a total of $775K across 4 funding rounds to date.
Developer of nanofiber-based wound care devices. It develops Phoenix Wound Matrix, a nanofiber product that mimics the extracellular matrix found naturally in the body. It can be used for the treatment of pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled or undermined wounds, surgical wounds, and trauma wounds.
RenovoDerm's top competitors include Imbed Biosciences, Organogenesis and Cour Pharma.
RenovoDerm offers Phoenix Wound Matrix and Anthem Wound Matrix.